Hong Kong, China

Man Yik Li


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Man Yik Li in Veterinary Medicine

Introduction

Man Yik Li is a noteworthy inventor located in Hong Kong, China. With a keen focus on developing effective treatments for animal health, Li has made significant advancements in the formulation of veterinary medications.

Latest Patents

Li is recognized for his patent in a macrocyclic lactone tablet formulation. This innovative invention pertains to a tablet designed for administration to animals in order to combat parasite infestations. The tablet is notable for its inclusion of at least one macrocyclic lactone compound with anthelmintic activity that is dissolved in an organic solvent and subsequently formulated into a tablet. The resulting tablets are exceptionally stable over time and provide animals with sufficient dosages to ensure therapeutic effectiveness.

Career Highlights

Man Yik Li is associated with Bayer New Zealand Limited, a company renowned for its commitment to advancing agricultural and pharmaceutical innovations. Through his work, Li has positioned himself at the forefront of research that enhances animal health and wellbeing.

Collaborations

Li collaborates with talented professionals in the industry, including coworkers such as Karthigeyan Nanjan and Fadil Al Alawi. These collaborations reflect a collective effort towards achieving breakthroughs in veterinary formulation and treatment.

Conclusion

In conclusion, Man Yik Li has made significant strides in the veterinary field with his innovative macrocyclic lactone tablet formulation. His work at Bayer New Zealand Limited, combined with valuable collaborations, underscores his commitment to improving animal healthcare solutions and highlights the importance of continued innovation in this essential industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…